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ABSTRACT
Background: The purpose of this paper was to examine national differences in the desire to
participate in decision-making of people with severe mental illness in six European countries.
Methods: The data was taken from a European longitudinal observational study (CEDAR;
ISRCTN75841675). A sample of 514 patients with severe mental illness from the study
centers in Ulm, Germany, London, England, Naples, Italy, Debrecen, Hungary, Aalborg,
Denmark and Zurich, Switzerland were assessed as to desire to participate in medical
decision-making. Associations between desire for participation in decision-making and center
location were analyzed with generalized estimating equations.
Results: We found large cross-national differences in patients’ desire to participate in
decision-making, with the center explaining 40% of total variance in the desire for
participation (p<0.001). Averaged over time and independent of patient characteristics,
London (mean=2.27), Ulm (mean=2.13) and Zurich (mean=2.14) showed significantly higher
scores in desire for participation, followed by Aalborg (mean=1.97), where scores were in
turn significantly higher than in Debrecen (mean=1.56). The lowest scores were reported in
Naples (mean=1.14). Over time, desire for participation in decision-making increased
significantly in Zurich (b=0.23) and decreased in Naples (b=-0.14). In all other centers,
values remained stable.
Conclusions: This study demonstrates that patients’ desire for participation in decision-
making varies by location. We suggest that more research attention be focused on identifying
specific cultural and social factors in each country to further explain observed differences
across Europe.
Keywords: Clinical decision-making, Patient participation, Multicenter study, Severe mental
illness
1. Introduction
Patients’ Autonomy
One of the first empirical studies on patient participation in medical decision-making
examined whether patients wish to make decisions themselves [1]. Autonomy refers to the
decision-making dimension of the patient’s role, and enhancing patient autonomy means
helping patients to make their own decisions [2]. Considerations of a patient’s autonomy in
the health care context tend to focus most strongly on the idea that patients should be
allowed and enabled to make autonomous decisions about their health care [3-5]. Patient
involvement and patient participation in decision-making are therefore regarded as a feature
of good quality of care, which is valued in its own right [6,7]. Nowadays, autonomy is a key
concern in biomedical ethics and many countries have passed legislation to protect patients’
autonomy and to provide informed consent for medical interventions [3].
Shared Decision-Making
Shared decision-making means that information exchange is a two-way process
during consultation. Both the health care professional and the patient engage in deliberation
and take the decision. Self-determination of patients and their right to a comprehensive
explanation of the illness and all its treatment possibilities are the fundamental prerequisites
of this model [8]. The model contrasts with (i) the ‘paternalistic’ model, where information is
given to the patient and the deliberation and decision are made by the health care
professional, or (ii) an ‘informed’ model, where information is given to the patient and the
patient deliberates and decides [9]. The NICE (National Institute for Clinical Excellence) has
continuously promoted shared decision-making by ensuring that its clinical guidelines
address issues of importance to both patients and health care professionals [10]. Shared
decision-making is recommended in systematic reviews [11].
Preferences for participation in decision-making among patients with serious mental
illness
Reviews of shared decision-making in persons with schizophrenia [8] and depression
[12] showed that patients and physicians found shared decision-making acceptable and did
in fact engage in shared decision-making, which resulted in improvements in patients’
knowledge about their illness and a higher level of perceived involvement in decision-making.
Patients generally express a desire for greater participation in decision-making about
psychiatric care than what they are currently experiencing. Concerning the use of new
psychiatric medication, most participants prefer autonomous or shared roles. A passive role
in medication decisions in psychiatric care was observed to be less likely than a passive role
in general medical care [13].
Hamann et al. [8] showed that the desire to participate in decision-making was higher
in inpatients with experiences of involuntary treatment, with negative attitudes toward
medication, with a higher level of education, with lower treatment satisfaction (e.g. general
treatment satisfaction, trust in clinicians, and fairness), with better-perceived decision-making
skills, in patients of female gender and in younger patients., It was, furthermore,
demonstrated that patients with schizophrenia strongly wish to participate in medical
decisions on an equal footing with their doctors, rather than to completely take over
decisional control [8, 14, 15]. Moreover, a large study in the United States with a focus on
outcomes in adults diagnosed with depressive disorders showed that greater involvement in
depression care resulted in higher participant satisfaction and lower depression scores [16].
In the CEDAR study people with severe mental illness stated a preference for a shared
decision-making style [17]. Patients indicated that involvement in decision-making during
their last treatment session was mainly shared (shared decision model) [17] and most people
wanted to receive information on all aspects of their treatment [18].
Influence of Culture
There is little knowledge about what actually constitutes ‘cultural’ differences in
mental health. Triggered by socio-political factors (among others), participation preferences
are considered to have increased in the past decades [19, 20]. Movements promoting the
rights of citizens, consumers and patients, who in western countries have become
increasingly active since the 1960s, are considered to have changed the ‘culture’ of the
medical health care system [21, 22]. Overall, ‘culture’ is reported to be an important factor
explaining differences in patients’ preferences, but results remain inconsistent [15]. The
extent to which patients expect to be actively involved in treatment decisions varies
according to the prevailing medical culture. If it is paternalistic, both doctors and patients are
likely to assume that decisions are the responsibility of the doctor only, whereas in a more
egalitarian culture a partnership or shared decision-making approach may be preferred [23].
In a conceptual paper, Charles et al. [24] discussed the influence of culture on the
process of treatment decision-making and, in particular, shared treatment decision-making in
the physician-patient encounter. It was noted that the nature of the encounter is influenced
by cultural expectations, e.g. the patients’ and physicians’ role expectations and expectations
as to who is involved in decision-making. Finally, in the DIALOG trial (a computer-mediated
procedure to structure patient-clinician dialogue) the effectiveness of a novel intervention
was studied across six European community mental healthcare settings (incl. Germany, UK,
Switzerland, Spain). It was assessed whether the effectiveness of structured patient-clinician
communication varies between services in different countries. In the centers in which the
DIALOG intervention proved most effective (namely London and Granada), patients had
comparatively high symptom levels (London), more unmet needs for care, a shorter history in
mental healthcare and fewer hospital admissions (London and Granada) [25].
Although patients' involvement and participation in decision-making is regarded as a
feature of good quality of care [3], little is known about national differences in the preferences
for participation in decision-making of people with severe mental illness. The main objective
of the present study was thus to study whether patients’ participation preferences differed
across six European countries, both in addition to and independent of patient characteristics.
Since patients’ preferences are likely to develop over time and may change at different
stages of their illness [17, 26], we also examined whether there was an interaction effect
between study center and time. Based on the literature we hypothesized that the desire for
participation in decision-making would vary substantially across countries.
2. Material and methods
Sample
The data were taken from the study “Clinical Decision-making and Outcome in
Routine Care for People with Severe Mental Illness“ (CEDAR; ISRCTN75841675) [17].
CEDAR is a naturalistic prospective longitudinal observational study with bimonthly
assessments during a 12-month observation period (T0-T6) carried out in six European
countries (Germany, UK, Italy, Hungary, Denmark and Switzerland). First, CEDAR
established a methodology to assess clinical decision-making in people with severe mental
illness. Specific instruments were developed to measure clinical decision-making style, key
elements of clinical decision-making in routine care, as well as clinical decision-making
involvement and satisfaction from patient and clinician perspectives. Second, these
instruments were applied in a multi-national prospective observational study. This study
investigated the immediate, short- and long-term effect of clinical decision-making on crucial
dimensions of clinical outcome (symptom level, quality of life, needs) by taking into account
significant variables moderating the relationship between clinical decision-making and
outcome. Participants in the CEDAR study were recruited between November 2009 and
December 2010 from caseloads of outpatient/community mental health services at six
centers: Department of Psychiatry II, Ulm University, Germany (coordinating center); South
London and Maudsley NHS Foundation Trust, London, the U.K.; the Department of
Psychiatry at University of Naples SUN, Italy; the Department of Psychiatry at Debrecen
University, Hungary; the Unit for Psychiatric Research at Aalborg University Hospital (former
Aarhus University Hospital), Denmark; and the former Department of General and Social
Psychiatry at the University of Zurich, Switzerland. Ethics committees approved the study in
all centers. After being informed about the goal, the funding of the study, the right to refuse to
participate or to withdraw consent without adverse consequences, all participants gave their
written informed consent. The CEDAR study was conducted in accordance with the Helsinki
Declaration of 1975, as revised in 2008, of the World Medical Association [17].
The six study sites reflect the diversity across Europe in the organization of mental
health services. Ulm, Germany (coordinating center): The department is responsible for the
provision of mental health care in a large catchment area in rural Bavaria (population 671
000). Multidisciplinary teams (psychiatrists, psychologists, social workers, nurses and
occupational therapists) offer a full range of pharmacological and psychosocial interventions
in inpatient, outpatient and daycare clinics. The department collaborates closely with office-
based psychiatrists and psychotherapists in the area. London, UK: The site comprises three
specialist community teams: early psychosis, assertive outreach and rehabilitation and
recovery. All teams are multidisciplinary, comprising clinical psychology, nursing,
occupational therapy, psychiatry and social work professionals, as well as support workers
and administrative staff. These teams provide services across the London Borough of
Croydon (population 330 000) as part of a range of services for adults aged 18–65, including
three community mental health teams, a home treatment team, a community forensic team
and in-patient beds. Naples, Italy: The department includes inpatient and outpatient units and
a 1-day hospital. The outpatient units include specialist clinical teams for the management
and treatment of psychotic disorders, mood disorders, eating disorders and obsessive–
compulsive disorders. Specialist teams for early detection and management of psychoses
and for cognitive and psychosocial rehabilitation are available. Debrecen, Hungary: The
department provides in- and outpatient mental health care for the city of Debrecen
(population 200 000). The team is completed by an occupational therapist and a social
worker professional that maintain contact with the regional rehabilitation institutions and
mental homes. Aalborg, Denmark: The Psychiatry Region North includes various treatment
centers, including inpatient treatment, outpatient teams and early psychosis teams. The
collaborating centers in the CEDAR study were organized within the universities of Aarhus,
Aalborg, Copenhagen and Southern Denmark. Others were provincial hospitals with links to
Aarhus University. Furthermore, CEDAR collaborated with office-based psychiatrists. Zurich,
Switzerland: The department takes responsibility for a defined catchment area in Zurich City
of about 390 000 inhabitants. It comprises 488 beds and additionally offers specialized care
in a crisis center and a center for psychiatric rehabilitation [17].
A convenience sample of patients was recruited from mental teams. Potential patient
participants were identified by clinicians. The referring clinician asked patients who met
inclusion criteria to consent to researcher contact. A researcher then met the patient,
explained the study and obtained signed informed consent. In nearly all study centers the
patient nominated a key clinician of any profession whom they saw regularly. In Denmark, it
was reversed: patients were recruited via staff. Data was collected using questionnaires
(filled in by the patient and his or her key worker) or through interviews conducted by the
CEDAR researchers. Data entry was via computer or paper-pencil forms. See Puschner et
al. [27] for further details on the rationale and design of the CEDAR study.
Participating staff from the CEDAR study were in their mid-40s on average and their
mean time of working in mental health services was 15 years. The category of professions
included psychiatrists, psychologists, social workers and others (nurse, district nurse, support
time and recovery worker and psychiatric trainee) [27].
Participants
Inclusion criteria were: adult age (18-60 years) at intake, mental disorder of any kind as main
diagnosis established by case notes or staff communication using SCID criteria [28],
presence of severe mental illness (Threshold Assessment Grid (TAG) ≥ 5 points and illness 
duration ≥ 2 years; [29]); expected contact with mental health services (excluding inpatient
services) during the time of study participation; sufficient command of the host country’s
language; and capability of giving informed consent. Exclusion criteria were: main diagnosis
of learning disability, dementia, substance use or organic brain disorder; cognitive
impairment severe enough to make it impossible to give meaningful information on study
measures; and treatment by forensic mental health services [17].
A total of 708 patients were screened for eligibility, of which 588 were included. The
reason for exclusion was not meeting inclusion criteria (n=120). The study uses data of
participants (n=514) who completed the time points baseline (T0) and one-year follow-up
(T6). All data on patients’ socio-demographic and clinical characteristics were assessed
through the Client Sociodemographic and Service Receipt Inventory – European Version
(CSSRI-EU) questionnaire at baseline (T0) and at one-year follow-up (T6) [17].
Measures and Instruments
The Clinical Decision-Making Style (CDMS) [30] is an adaptation of the Autonomy
Preference Index (API; [1]) for use in people with severe mental illness. The subscale
“Participation in Decision-Making” (CDMS-PD) consists of 15 items, each rated on a five-
point Likert scale ranging from 0-4 (with a higher score indicating a higher desire by the
patient to be an active participant in decision-making). Categorical sum scores were
formulated on the basis of utility, where an emphasis was placed on separating categories
according to clinical meaningfulness. Categories of decision-making models according to the
CDMS-PD subscale were “passive” (CDMS-PD<1.5, defined as the clinician taking the
decision, with or without considering the views of the patient), “shared” (1.5-<=CDMS-
PD<=2.5, defined as decisions being made jointly between clinician and patient) and “active”
(CDMS-PD>2.5, defined as the patient taking the decision, with or without considering the
views of the clinician). These categories distinguish groups by their ordinal nature but not by
a specific value assigned to each category. The paternalistic model corresponds to a passive
involvement of the patient; the shared decision-making and the informed choice model
correspond to an active involvement of the patient. The CDMS was measured at baseline
(T0) and at one-year-follow-up (T6). For a detailed account of the CDMS, see Puschner et al.
[30].
Statistical Analysis
Baseline characteristics across centers were examined with contingency tables and
2 significance tests for categorical variables and with independent sample t-tests for
continuous variables. The repeated measures of participation in medical decision-making
over time were examined with a series of generalized estimating equations (GEE). These
models were introduced to fit regression analyses that account for within-subject correlation,
which is an inherent part of longitudinal studies that rely on repeated measures [31]. Owing to
the distribution of the dependent variable (CDMS-PD), a normal distribution with an identity
link-function best fitted our data. A robust maximum likelihood estimator was used to reduce
the effects of outliers and influential observations. The intercept and slope factor was
included in all analyses, which is a common procedure in longitudinal data modeling [32]. To
adjust for the within-subject correlation, the slope factor was also modeled as an interaction
effect with the predictor variable to examine changes in the desire to participate in decision-
making over time. To examine group differences, pairwise comparisons with sequential
Bonferroni correction for multiple testing were conducted. Interaction effects of categorical
and continuous predictors with the time-trend were indicated with unstandardized regression
coefficients (b). The proportion of total variance explained in the repeated outcome was
estimated with a pseudo-R2, which is obtained by dividing the variance of the full model (i.e.,
dispersion parameter) by the variance of the repeated dependent variable. All analyses were
carried out with SPSS version 20 for Macintosh.
3. Results
–Table 1–
The descriptive statistics are indicated in Table 1. For all variables the differences
across centers were statistically significant. According to a series of bivariate GEE
comprising center and the nine patient variables indicated in Table 1, center was the
substantially strongest bivariate predictor of participation in decision-making. Center
explained 39.9% of total variance in the CDMS-PD over time (2=529.065, df=5, p<0.001),
which corresponds to a large effect size. The highest mean CDMS-PD scores pooled over
time were reported in London (2.28), Ulm (2.14) and Zurich (2.15), followed by Aalborg
(1.98), which in turn was significantly higher than Debrecen (1.53). The distinctly and
statistically significantly lowest CDMS-PD score was reported in Naples (1.12). In Zurich, the
CDMS-PD increased significantly from t0 to t6, whereas in Naples it declined significantly
over time; at the other study sites it remained stable (see Table 2).
–Table 2–
Since patients’ characteristics between the respective centers differed significantly
(see Table 1), possible cultural differences on CDMS could be attributed to regional
differences as well as to distinct patient characteristics. Therefore, to answer the question of
whether cultural influences were independent of distinct patient characteristics across
centers, we regressed all nine predictors from Table 1 (i.e., gender, age, marital status,
ethnic group, years in school, living situation, employment status, state benefits and
diagnosis) separately on the CDMS-PD. Of the nine predictor variables listed in Table 1, age
(2=10.967, df=1, p=0.001), marital status (2=14.133, df=1, p<0.001), living situation
(2=36.674, df=2, p<0.001) and state benefits (2=6.628, df=1, p=0.010) were significantly
related to the repeated measures of the CDMS-PD according to bivariate GEE. These
variables were thus included in addition to center in a fully adjusted GEE model. We
additionally added the repeated TAG score, which is a measure of illness severity and which
also related weakly to the CDMS-PD (2=5.954, df=1, p=0.015). In this multivariate model,
only center (2=184.221, df=5, p<0.001) and the interaction term between center and time
(2=33.244, df=6, p<0.001) remained statistically significant predictors of the CDMS-PD. The
results for center are shown in Table 3. The adjustment for significant covariates did not alter
the results substantially. In accordance with the unadjusted analysis, London (2.27), Ulm
(2.15) and Zurich (2.14) showed the highest pooled CDMS scores over time, followed by
Aalborg (1.96), Debrecen (1.54), and Naples (1.14). In this multivariate model, we again
observed a significant increase in the CDMS-PD over time in Zurich as well as a significant
decrease over time in Naples.
–Table 3–
4. Discussion
The aim of this study was to examine differences between European countries in
patients’ participation in medical decision-making by focusing on psychiatric services in six
different European countries. We found large differences between the study centers in
patients’ wishes to participate in decision-making, with the center location as the predictor
variable explaining 40% of total variance in the CDMS-PD. Moreover, those national
differences were independent of patient characteristics including gender, age, marital status,
ethnic group, years in school, living situation, employment status, state benefits and
diagnosis
Participants from North-western Europe (Ulm, London, Aalborg and Zurich) showed
moderate scores over time on CDMS-PD, indicating a preference for shared decision-
making, with a higher preference for active decision-making mainly in Ulm, London and
Zurich. On the other hand, participants from Southern Europe (Naples) showed a preference
for passive decision-making. While participants from Zurich increased in their wish to
participate in decision-making over time, the opposite was observed in Naples, where
participants’ initial low preference for autonomous decision-making declined further after
twelve months.
Our results are in line with the results of a study on communication, information, involvement
and choice in clinical decision-making, in which 1000 interviews were carried out in nine
countries (e.g. UK, Germany, Poland, Italy) with random samples of the adult population. The
results show that a more paternalistic view of the doctor–patient relationship prevailed in
Poland and Spain compared to the six other countries: 91% of Swiss and 87% of German
respondents believed that the patient should have a key role in treatment decisions, either by
sharing responsibility with the doctor or by being the primary decision-maker. The proportion
of Polish patients who shared that opinion was only 59%, and in Spain it was only 44% [33].
Similar results were obtained in a study with patients with urinary incontinence. In this study,
preferences for involvement in treatment decision-making in 15 European countries were
explored. Women in North-western European countries (e.g. Germany, UK and Switzerland)
wished to be involved in the treatment decision-making process with a collaborative role.
Women in Denmark opted for a more active role, preferring more active involvement than
women in Southern European countries (e.g. Greece, Portugal, Spain), where passive
involvement was clearly favored. The results suggest that particularly in Southern European
countries many women prefer a passive role in treatment decision-making [34]. Cultural
barriers – for example, patients’ and health professionals’ beliefs about their roles within the
consultation – may be hard to overcome in some countries. It is therefore important that
professionals are prepared to support patients in this process. For instance, patients are
unlikely to become involved in self-management education programmes if they do not
believe they have a key part to play in managing their health. Social inequalities may also
inhibit changes in patient involvement. Those with lower levels of education and lower
incomes may feel less confident about becoming involved in their care and in evaluating
health information. They are also less likely to have access to computers and the Internet.
The digital divide is more apparent in some European countries than in others. A survey of
citizen’s use of e-health services found that health-related use of the Internet was most
frequent in northern European countries, such as Denmark (62%), Norway (59%) and
Germany (49%) [35, 36]. Eastern European countries such as Poland and Latvia reported a
42% and 35% health-related use of the Internet, respectively, while southern Europe had the
lowest proportion of Internet health users, with 30% in Portugal and 23% in Greece [35]. A
recent study found that Hispanics preferred a more passive role in mental health decision-
making while non-Hispanics preferred a more active role. The authors discussed several
reasons for these findings. Some of them could be applied to our findings. First, patients’
health worldview, including health belief models, treatment preferences, involvement of
family, greater trust in their physician and attitude may vary and influence a patient’s
preference for participation (influence by cultural attitudes and tradition) [37-40]. Second,
perceived lack of knowledge, lack of self-efficacy or a learned response influenced by
cultural attitudes may contribute to this as well [38-40]. Further potential reasons identified
were the distinct organizational models in operation in the six European countries, which may
lead to different ways of thinking about participation in medical decision-making,
competence, vulnerability and risk to self, which raise particularly difficult issues in psychiatry
[41-43].
In some countries (e.g. Switzerland), patients can immediately visit a specialist clinician if
they wish so, while in others (e.g. Italy, Denmark and England), patients must first secure a
referral from a GP. The right to choose the timing and location of hospital treatment is well
established in some countries (e.g. Germany), whereas long waits and limited choice of
location are standard in others (e.g. UK). Policy makers in the UK and elsewhere are
attempting to speed up access by making it easier for patients to travel to hospitals with
spare capacity if they wish to [23]. Another reason could be that some patients’ wish for
passivity may be genuine and may reflect their wish to be taken care of or to be free of
responsibility for treatment failure [44]. A further reason is the influence of the physician’s
expectations of patient role. There is evidence of differences between doctors in eastern and
western Germany concerning the nature of ‘right’ treatment and the ‘right’ patient role. In
summary, physicians in the east have more paternalistic attitudes toward patients. This data
is mirrored by a telephone survey showing that patients from Poland view their doctors as
more paternalistic than patients in most western European countries. Thus, patients (in
eastern Germany) who have experienced more paternalistic doctors already expect a more
passive role [14, 15]. In general, culture has so far been mostly neglected in the medical
literature on treatment decision-making [24] and we can only comment on its possible
influence on role preferences. Further research would be required to identify specific cultural
and social factors in each country that might explain the observed cross-national differences.
5. Limitations
There are some limitations that have to be addressed. The primary limitation was that
sample characteristics were heterogeneous across centers, which could decrease
comparability and generalizability of our findings. A further limitation was that the CDMS was
only measured twice instead of several times and that the CEDAR study lasted only one
year. Having more measurement occasions would be useful to develop a better
understanding of how patients’ wish for participation might change over time and to better
understand the complexity of medical decision-making in mental health services.
Furthermore, only six different countries were examined. Additional countries and different
locations within the same country would enhance both international comparability and
interpretation of the results. Furthermore, our study focused only on “culture” and “patient
characteristics” as factors that influence patients’ preferences for involvement in decision-
making. Other factors (e.g. the amount of knowledge patients have acquired about their
condition) that influence patients’ preference for involvement in decision-making were not
considered in detail in this study. Another limitation is the patients’ self-reported preferences
and the failure to consider the impact of professional preferences on the results. In this paper
only patient perspectives were considered. It is well established that attitudes do not
immediately relate to behavior. Thus, for example, a patient who expresses high participation
preferences in the questionnaire might at the same time behave entirely passively during a
consultation because his doctor behaves very authoritatively. There is also evidence that
patients - to varying extents - learn to present themselves and their illness according to cues
from professionals. This learning process may also in part explain the changes over time in
preferences observed. Finally, no data was collected about the cultural and social aspects of
the professionals involved and the study sites are very distinct from one another. For further
studies on this topic, the factors mentioned should be taken into account.
6. Conclusions
The data shows that center location has an impact on the patients’ desire for
participation in decision-making. The influence of location has so far been a relatively
neglected topic in the medical literature on treatment decision-making. Cultural influences
can be a major factor affecting the dynamics of the physician–patient interaction, the type of
decision-making process used, the potential for reaching a mutually agreed upon decision,
and the satisfaction of both parties with both the process and the treatment decision. More
research in these areas is certainly needed [22]. Involving patients in decision-making is one
of many ways through which quality of health care could be improved [45]. Preference for
participation in medical decision-making varies widely. Involvement may not be acceptable or
appropriate for everyone [17, 18]. Patients should be empowered so that they experience the
benefits associated with involvement. Among other things, empowerment (i.e. within mental
health services, including becoming an empowered member of society) is one of the
recovery processes that have the most proximal relevance to clinical research and practice
[46]. The current conceptualizations of recovery are primarily based on Western European
and North American models [47]. Empowerment may therefore relate to a particular cultural
value, which we found to be more present in Northern and Western Europe than in Central
and Southern Europe. This highlights the culture-specific values inherent in evidence-based
medicine, and the need to ensure that treatment approaches – especially in relation to
interpersonal processes - are consistent with local cultural values.
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Table 1: Baseline patient characteristics (N=514)
Patients Total (N=514) Ulm
(N=96)
London
(N=69)
Naples
(N=92)
Debrecen
(N=88)
Aalborg
(N=81)
Zurich
(N=88)
Center
differences
Gender
Female, n (%) 269 (52.30) 62 (64.60) 20 (29.00) 47 (51.10) 44 (50.00) 40 (49.40) 56 (63.60) p<0.001
Age
Years, M (SD) 41.61 (10.75) 45.29 (8.82) 37.05 (10.30) 41.93 (11.19) 45.17 (9.81) 39.76 (10.99) 38.97 (10.96) p<0.001
Marital Status
Married, n (%) 136 (26.50) 31 (32.30) 5 (7.20) 36 (39.10) 30 (34.10) 10 (12.50) 24 (27.30) p<0.001
Ethnic group
White, n (%) 487 (94.90) 96 (100.00) 45 (65.20) 92 (100.00) 88 (100.00) 80 (98.8) 86 (98.90) p<0.001
Years in school
Basic education, M (SD) 10.74 (2.24) 10.57 (1.73) 11.60 (1.73) 11.67 (3.98) 11.47 (1.17) 9.69 (1.09) 9.59 (1.32) p<0.001
Living situation
Alone, n (%)
Parents, n (%)
Other, n (%)
195 (38.20)
103 (20.20)
213 (41.60)
53 (55.20)
7 (7.30)
36 (37.50)
17 (24.60)
10 (14.50)
42 (60.90)
10 (11.00)
40 (44.00)
41 (45.00)
20 (22.70)
33 (37.50)
35 (39.80)
49 (60.50)
7 (8.60)
25 (30.90)
46 (53.50)
6 (7.00)
34 (39.50)
p<0.001
Employment Status
Employed, n (%) 97 (18.90) 25 (26.00) 1 (1.4) 25 (27.20) 15 (17.00) 6 (7.40) 25 (28.40) p<0.001
State benefits
Yes, n (%) 372 (72.40) 78 (81.20) 58 (84.10) 21 (22.80) 77 (87.50) 76 (93.80) 62 (70.50) p<0.001
Diagnosis
Psychotic disorder, n (%)
Mood disorder, n (%)
Other, n (%)
236 (45.90)
173 (33.70)
105 (20.30)
34 (35.40)
43 (44.80)
19 (19.80)
49 (71.00)
14 (20.30)
6 (8.70)
22 (23.90)
39 (42.40)
31 (33.70)
50 (56.80)
19 (21.60)
19 (21.60)
53 (65.40)
19 (23.50)
9 (11.10)
28 (31.80)
39 (44.30)
21 (23.90)
p<0.001
Table 2: Repeated measurement of the CDMS1 in association with center location
Means (SE) Pairwise comparisons
T0 T6 Pooled
Center Zurich, Switzerland
Aalborg, Denmark
Debrecen, Hungary
Naples, Italy,
London, England
Ulm, Germany
2.04 (0.06)
1.97 (0.06)
1.52 (0.04)
1.20 (0.06)
2.26 (0.07)
2.10 (0.05)
2.27 (0.04)
1.99 (0.06)
1.55 (0.05)
1.05 (0.04)
2.31 (0.08)
2.18 (0.06)
2.15 (0.04)
1.98 (0.05)
1.53 (0.04)
1.12 (0.04)
2.28 (0.07)
2.14 (0.05)
Zurich, London, Ulm > Debrecen > Naples
London > Aalborg > Debrecen > Naples
b 95% CI Sig.
Zurich * Follow-up
Aalborg * Follow-up
Debrecen * Follow-up
Naples * Follow-up
London * Follow-up
Ulm * Follow-up
0.230
0.022
0.034
–0.150
0.055
0.085
0.147; 0.312
–0.066; 0.111
–0.064; 0.133
–0.277; –0.024
–0.107; 0.217
–0.010; 0.180
0.000
0.625
0.492
0.020
0.506
0.079
1CDMS: Clinical Decision Making Style
Table 3: Repeated measurement of the CDMS1 in association with center location, adjusted for patient’s age, marital status, living
situation, state benefits, as well as repeated TAG scores
Means (SE) Pairwise comparisons
T0 T6 Pooled
Center Zurich, Switzerland
Aalborg, Denmark
Debrecen, Hungary
Naples, Italy,
London, England
Ulm, Germany
2.03 (0.06)
1.95 (0.07)
1.54 (0.05)
1.21 (0.06)
2.23 (0.08)
2.10 (0.05)
2.26 (0.05)
1.99 (0.07)
1.58 (0.05)
1.07 (0.05)
2.31 (0.10)
2.17 (0.07)
2.14 (0.05)
1.97 (0.06)
1.56 (0.05)
1.14 (0.04)
2.27 (0.08)
2.13 (0.05)
Zurich, London, Ulm > Debrecen > Naples
London > Aalborg > Debrecen > Naples
b 95% CI Sig.
Zurich * Follow-up
Aalborg * Follow-up
Debrecen * Follow-up
Naples * Follow-up
London * Follow-up
Ulm * Follow-up
0.233
0.042
0.037
–0.143
0.075
0.074
0.132; 0.335
–0.055; 0.140
–0.062; 0.135
–0.272; –0.014
–0.100; 0.250
–0.031; 0.179
0.000
0.391
0.464
0.030
0.401
0.165
1CDMS: Clinical Decision Making Style

